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Abstract 28 
Titin provides a molecular blueprint for muscle sarcomere assembly and sarcomere length can vary 29 
according to the expression of different titin isoforms, which may influence muscle fascicle length and 30 
consequently provide an advantage for running performance. Thus the aim of this study was to 31 
investigate if the titin (TTN) rs10497520 polymorphism was associated with muscle fascicle length in 32 
recreationally active men (RA; n = 137) and marathon personal best time in male marathon runners 33 
(MR; n = 141).  Fascicle length of the vastus lateralis was assessed in vivo using B-mode 34 
ultrasonography at 50% of muscle length in RA.  All participants provided either a whole blood, saliva 35 
or buccal cell sample, from which DNA was isolated and genotyped using real-time polymerase chain 36 
reaction.  Vastus lateralis fascicle length was 10.4% longer in CC homozygotes than CT heterozygotes 37 
(p = 0.003) in RA.  In the absence of any TT homozygotes, reflective of the low T-allele frequency 38 
within Caucasian populations, it is unclear if fascicle length for this group would have been smaller 39 
still.  No differences in genotype frequency between the RA and MR groups were observed (p = 40 
0.500), although within the MR group the T-allele carriers demonstrated marathon personal best times 41 
2 min 25 s faster than CC homozygotes (p = 0.020).  These results suggest that the T-allele at 42 
rs10497520 in the TTN gene is associated with shorter skeletal muscle fascicle length and conveys an 43 
advantage for marathon running performance in habitually trained men. 44 
 45 
Keywords: Gene polymorphism, muscle architecture, endurance athletes, mechanical efficiency  46 
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Introduction 47 
The titin gene (TTN) encodes the largest described protein to date, which is the third most abundant 48 
protein within the myofilament of human striated muscle (Vikhlyantsev & Podlubnaya 2012).  Titin 49 
provides a molecular blueprint for the assembly and organisation of the thin and thick filaments during 50 
myofibrillogenesis (Chauveau et al. 2014).  Seven splice isoform variants of titin exist within human 51 
striated muscle, which each differ in size and elasticity (Chauveau et al. 2014; Vikhlyantsev & 52 
Podlubnaya 2012).   53 
 54 
A missense C>T transition (rs10497520) identified within human TTN has been reported to contribute 55 
to the variability in the training response of maximal oxygen consumption (VO2max) in previously 56 
untrained individuals (Timmons et al. 2010).  Within cardiac muscle, titin is suggested to be a key 57 
regulator of the Frank-Starling mechanism (Fukuda et al. 2001), and considering the substantial 58 
differences in the elasticity of cardiac titin isoforms (Wang et al. 1991), this C>T transition may 59 
contribute to the variability within titin isoform expression.  Accordingly, differences in the titin 60 
isoforms expressed may explain the TTN-related increases in stroke volume (Rankinen et al. 2003) and 61 
consequently VO2max following endurance exercise training Timmons et al. (2010).  Furthermore, if 62 
this TTN polymorphism influences titin isoform expression in cardiac muscle as speculated, there 63 
exists a distinct possibility that a similar influence is occurring within skeletal muscle tissue.   64 
 65 
In skeletal muscle, the predominant titin isoform is N2A, of which a smaller (T1) and larger (T2) 66 
isovariant exist within humans (Fry et al. 1997).   A recent study, which identified a TTN mutation that 67 
alters isoform splicing in rats, demonstrated an association between isoform size and sarcomere 68 
length; with significantly longer resting sarcomere lengths corresponding to the larger mutant titin 69 
isoforms (Greaser & Pleitner 2014; Greaser et al. 2008).  Assuming the findings of these animal 70 
studies can be extrapolated to human populations, it stands to reason that for individuals with an equal 71 
number of serial sarcomeres, fascicles would be longer in those expressing more of the larger titin 72 
isoforms and vice versa for those expressing more of the smaller titin isoforms.  It is important to note, 73 
4 
 
however, that sarcomere length (like titin isoform expression) is not homogeneous within a muscle 74 
(Greaser et al. 2005; Wickiewicz et al. 1983).   75 
 76 
If TTN-dependent differences in skeletal muscle fascicle length are apparent, variability in muscle 77 
functional phenotypes might also be expected.  For instance, muscle maximal shortening velocity 78 
(Vmax) is positively correlated with fascicle length (Bodine et al. 1982; Sacks & Roy 1982).  Although 79 
no direct associations between TTN and fascicle length have been reported, the aforementioned C>T 80 
transition within the TTN gene has been identified as contributing significantly to a genetic 81 
predisposition for maximal isokinetic strength at 180°∙s-1 but not 60°∙s-1 (Thomaes et al. 2013), which 82 
could indirectly demonstrate that variability in Vmax is influenced by genotype-dependent differences 83 
in fascicle length.  Furthermore, enhanced efficiency of stretch-shortening contractions can be 84 
expected in individuals possessing shorter muscle fascicles due to the lower metabolic cost of 85 
producing a given force.  More specifically, shorter fascicles produce the same force per unit cross-86 
sectional area as longer fascicles, but when producing a given force, a smaller volume of muscle is 87 
activated in individuals possessing shorter fascicles (Pontzer et al. 2009; Roberts et al. 1998).  88 
Accordingly, vastus lateralis and gastrocnemius muscle fascicle length is shorter in elite distance 89 
runners than elite sprinters and untrained controls, and longer in elite sprinters than untrained controls 90 
(Abe et al. 2000).  Shorter fascicles in elite distance runners are likely to contribute to improved 91 
mechanical efficiency, whereas the longer fascicles observed in elite sprinters is likely to contribute to 92 
enhanced Vmax.  To date, however, it remains unclear whether these differences in the muscle 93 
architecture of elite runners are the result of adaptations to training or genetic variation. 94 
 95 
Consequently, the present study aimed to investigate if the TTN rs10497520 polymorphism was 96 
associated with muscle fascicle length in recreationally active men, and to investigate if TTN genotype 97 
distribution differed between recreationally active men and trained male marathon runners.  It was 98 
hypothesized that the TTN polymorphism would be associated with muscle fascicle length in 99 
recreationally active men, and the genotype associated with shorter fascicle length in this population 100 
would be overrepresented in trained marathon runners. 101 
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 102 
Materials and methods 103 
The sample comprised 278 healthy, unrelated Caucasian men who were categorised as either 104 
recreationally active [RA; n = 137, age 20.6 (2.3) yr, height 1.79 (0.06) m, mass 75.1 (10.1) kg; mean 105 
(standard deviation; SD)] or habitually trained marathon runners [MR; n = 141, age 34.9 (7.8) yr; 106 
height 1.79 (0.07) m, mass 66.5 (6.7) kg].  RA participants had a body mass index (BMI) between 107 
18.5 kg∙m-2 and 30 kg∙m-2, self-reported as not having a known musculoskeletal or neurological 108 
disorder and had not undertaken any structured training in the preceding 12 months.  MR participants 109 
comprised Olympic, international and national level marathon runners and had all achieved marathon 110 
personal best times under 2 hr 36 mins (range ~2 hr 7 mins to ~2 hr 35 mins).  MR participants were 111 
primarily recruited from London Marathon competitors during 2013-2015 and regional athletics clubs 112 
and organisations.  All participants gave written informed consent to participate in this study, which 113 
received approval from the Ethics Committee of Manchester Metropolitan University and complied 114 
with the Declaration of Helsinki. 115 
 116 
Muscle fascicle length of the vastus lateralis (VL) was measured in vivo using B-mode 117 
ultrasonography (AU5, Esaote, Italy) for each RA participant.  VL muscle length of the right limb was 118 
measured at rest following identification of the VL origin and insertion, whilst participants were 119 
standing upright with knees extended and relaxed (Abe et al. 2000).  Whilst in this position, ultrasound 120 
scans were taken at 50% of VL muscle length, in the mid-sagittal plane, using a 40 mm wide, 7.5 MHz 121 
linear-array probe positioned perpendicular to the skin.  Although the knee joint angle during standing 122 
does not correspond to that of optimal force production during running (Novacheck 1998; Tsuji et al. 123 
2015), measurement of fascicle length in this position is highly reproducible.  Each ultrasound scan 124 
was recorded using a 25 Hz sampling frequency in audio video interleave (AVI) format and frame-125 
capture software (Adobe Premiere Elements version 10, Adobe Systems) was used to capture single 126 
images for subsequent analysis.  The distance between fascicular origin in the lower aponeurosis and 127 
insertion in the upper aponeurosis was measured as fascicle length using digitizing software (NIH 128 
ImageJ, version 1.44o, National Institute of Health, Bethesda, Maryland).  Estimation of fascicle 129 
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length was necessary for those fascicles extending beyond the ultrasound field of view, which was 130 
achieved by extrapolating the fascicle and aponeuroses (Reeves & Narici 2003).  For each participant 131 
a minimum of three fascicles were measured and a mean of these was taken as fascicle length.  Due to 132 
the field-based nature of data collection within MR, it was not possible to obtain measurements of 133 
fascicle length in this population.   134 
 135 
All participants provided either a blood, saliva or buccal cell sample using the following protocols.  136 
For blood sampling, a 5 mL sample was taken from a superficial forearm vein into EDTA tubes (BD 137 
Vacutainer Systems, Plymouth, UK) and stored at -20°C.  Saliva samples were collected following a 138 
minimum 30-minute abstinence from food and drink into Oragene DNA OG-500 collection tubes 139 
(DNA Genotek Inc., Ontario, Canada) in accordance with the manufacturer’s guidelines and stored at 140 
room temperature.  Buccal cell samples were collected in duplicate (Whatman Sterile, OmniSwab, GE 141 
Healthcare, USA) following a minimum 1-hour abstinence from food and drink.  Participants were 142 
instructed to brush one OmniSwab collection tip firmly against the inside of the cheek for 143 
approximately 30 s and repeat with a second swab on the opposite cheek.  Each collection tip was 144 
ejected into a 2 mL microcentrifuge tube and stored at -20°C.   145 
 146 
The Qiagen QIAcube spin protocol (Qiagen, Crawley, UK), used for the extraction of genomic DNA 147 
from whole blood, saliva and buccal cell samples, was completed in accordance with the 148 
manufacturer’s guidelines and used the buffers contained in the Qiagen DNA Blood Mini Kit.  Each 149 
participant was genotyped for the TTN rs10497520 polymorphism, using real-time PCR on 96-well 150 
plates.  The 10 μL reaction volume, for genotyping using DNA obtained from whole blood or saliva 151 
samples, contained 0.2 μL of participant DNA [9.9 (1.1) ng, amounts determined using ~20% of 152 
participant DNA samples], 5 μL of TaqMan genotyping master mix (Applied Biosystems, Paisley, 153 
UK), 4.3 μL of nuclease-free H2O (Qiagen) and 0.5 μL of TaqMan SNP genotyping assay (Applied 154 
Biosystems).  For DNA samples obtained from buccal cells, the 10 μL reaction volume contained 1 μL 155 
of participant DNA [18.6 (4.6) ng], 5 μL of TaqMan genotyping master mix, 3.5 μL of nuclease-free 156 
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H2O and 0.5 μL of TaqMan SNP genotyping assay.  In the control wells, the DNA sample was 157 
replaced by nuclease-free H2O. 158 
 159 
DNA amplification (StepOnePlus Real-Time PCR System, Applied Biosystems) was completed using 160 
the following protocol: an initial 10 min at 95°C followed by 40 cycles of denaturation for 15 s at 161 
92°C, primer annealing and extension for 1 min at 60°C and plate read.  TTN genotype was 162 
subsequently determined using StepOnePlus analysis software version 2.3 (Applied Biosystems).  163 
Genotypes were called based on reporter dye intensity and visualized using cluster plots. The TaqMan 164 
assays included VIC and FAM dyes that for rs1049752 indicated C and T alleles on the forward DNA 165 
strand, respectively. Thus, VIC/FAM were interpreted as: 5′- TCCAACTT[C/T]AGGTTCTT -3′. All 166 
samples were analysed in duplicate and 100% agreement between all duplicate samples was achieved. 167 
 168 
Genotype frequency of the TTN rs10497520 polymorphism was assessed for compliance with Hardy-169 
Weinberg equilibrium using a X2 test.  Due to the low number of TT homozygotes in the whole sample 170 
(RA, n = 0; MR, n = 1), CC homozygotes were compared to T-allele carriers within each sub-group 171 
(RA, CC vs. CT; MR, CC vs. CT+TT).  Independent samples t-tests were conducted to determine any 172 
significant differences in physical characteristics (height, mass, BMI and age) between RA and MR, 173 
and according to genotype.  Additionally, independent samples t-tests were conducted to identify any 174 
genotype differences in fascicle length in RA and marathon personal best time in MR.  Pearson’s X2 175 
tests were used to compare genotype frequencies between MR and RA.  All statistical analyses were 176 
performed using SPSS version 21 and alpha was set at 0.05.  Data are presented as mean (SD) unless 177 
otherwise stated. 178 
 179 
Results 180 
Genotype frequency of the TTN rs10497520 polymorphism was in Hardy-Weinberg equilibrium for 181 
the whole sample and both the RA and MR sub-groups (Table 1).  MR were older and had lower mass 182 
(~9 kg) and BMI than RA (all differences p ≤ 1.0 x 10-13), but there was no difference in height (p = 183 
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0.660).  Genotype was not associated with mass, BMI or height either within the RA or MR 184 
subgroups, nor in the combined sample of 278 participants (p ≥ 0.376; Table 1). 185 
 186 
In the RA sub-group, VL fascicle length was 10.4% longer in CC homozygotes than in CT 187 
heterozygotes (p = 0.003; Figure 1).  There were no differences in genotype frequency between the 188 
RA and MR groups (X2 = 1.385, p = 0.500).  However, marathon personal best time was significantly 189 
lower in T-allele carriers compared to CC homozygotes in the MR group [2:26:28 (0:06:23) vs. 190 
2:28:53 (0:05:50); p = 0.020; Figure 2]. 191 
 192 
Discussion 193 
The aims of the present study were to investigate whether VL muscle fascicle length was associated 194 
with TTN rs10497520 genotype in recreationally active Caucasian men, and to identify whether 195 
differences in genotype frequency were evident between recreationally active individuals and trained 196 
marathon runners.  This study is the first to show a genetic influence on muscle architecture; 197 
specifically, the results demonstrate that VL muscle fascicle length was significantly longer in TTN 198 
CC homozygotes compared to CT heterozygotes in RA.  This is also the first time marathon 199 
performance in trained runners was associated with TTN genotype, with T-allele carriers performing 200 
significantly better than CC homozygotes.  201 
 202 
Titin acts as a template for myofibrillar protein assembly during sarcomere formation and provides an 203 
attachment site for a plethora of myofibrillar proteins to maintain the structural integrity of the 204 
sarcomere (Chauveau et al. 2014).  This protein is therefore likely to play a key role in the architecture 205 
of skeletal muscle, possibly affecting the serial arrangement of sarcomeres and, therefore, the length of 206 
muscle fascicles (Greaser & Pleitner 2014; Greaser et al. 2008).  Mean VL fascicle length in the RA 207 
group [7.1 (1.5) cm] was comparable to some previous reports of VL fascicle length (~7 cm) (Abe et 208 
al. 2000; Fukunaga et al. 1997), but less than others (~8 cm and ~9 cm) (Erskine et al. 2009; Reeves et 209 
al. 2004).  Differences in participant positioning and muscle activation during the measurement of 210 
muscle fascicle length are likely to explain the reported differences between the present study and 211 
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reports elsewhere (Fukunaga et al. 1997).  Indeed, VL fascicle length was measured during standing 212 
with the knees extended and relaxed in the present study, which was similar to those studies reporting 213 
comparable fascicle lengths (Abe et al. 2000; Fukunaga et al. 1997).  Those studies observing longer 214 
muscle fascicle lengths positioned the knee at 60-90 flexion and obtained measurements during 215 
maximal voluntary contraction (Erskine et al. 2009; Reeves et al. 2004). 216 
 217 
The TTN genotype and allele frequencies observed in the present study were similar to previous 218 
reports in Caucasian populations (www.hapmap.org) (Gibbs et al. 2003).  In the present study, 219 
individuals homozygous for the major C-allele had longer VL fascicles than heterozygotes, but as no 220 
individuals homozygous for the minor T-allele were present in the RA group, reflective of the low 221 
frequency of the T-allele within a Caucasian population, it is unclear if the VL fascicles of TT 222 
homozygotes would have been smaller still.  Future research should attempt to replicate the observed 223 
association between TTN and fascicle length on larger cohorts that include a sufficient number of TT 224 
homozygotes.  Based on the T-allele frequency we observed, future studies would require 2000 225 
participants to recruit 20 TT homozygotes.  A “stress the genotype” approach (Montgomery et al. 226 
2002) could help prioritise recruitment of TT homozygotes prior to conducting time-consuming 227 
phenotype assessments. 228 
 229 
Nonetheless, it is possible that the presence of the T-allele affects TTN splicing thus increasing 230 
expression of a smaller titin isoform within the muscle fascicles of heterozygotes.  To date, seven 231 
different titin splice isoforms have been identified within human striated muscle that each differ in size 232 
(Vikhlyantsev & Podlubnaya 2012).  Within human skeletal muscle, the predominant titin isoform is 233 
N2A, of which two isovariants (T1 and T2) are known to exist (Fry et al. 1997).  Thus, it is possible 234 
that altered TTN splicing, due to the presence of the T-allele, may influence the expression of these 235 
N2A isovariants and might explain the current observations.  Earlier studies in rat cardiac muscle 236 
support these possibilities by demonstrating a link between a TTN mutation and alternative isoform 237 
splicing (Greaser et al. 2005) and, more recently, TTN was associated with both cardiac and skeletal 238 
muscle sarcomere length in rats (Greaser & Pleitner 2014; Greaser et al. 2008).   239 
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 240 
Considering the observed association between TTN genotype and VL fascicle length, it was 241 
hypothesized that T-allele carriers would be overrepresented in habitually trained marathon runners 242 
because shorter fascicles require less energy to produce a given force, which is likely to contribute to 243 
improved mechanical efficiency in this population (Pontzer et al. 2009).  No difference, however, in 244 
TTN genotype distribution was observed between the RA and MR groups.  Nonetheless, the MR T-245 
allele carriers (those expected to possess shorter fascicles according to our RA data) had marathon 246 
personal best times 2 min 25 s faster than MR CC homozygotes.  This observation is consistent with 247 
previous reports of elite distance runners possessing shorter fascicles than both untrained individuals 248 
and elite sprinters (Abe et al. 2000).  Thus, possession of the T-allele, whilst not essential for 249 
successful marathon running performance, might convey an advantage for marathon running when 250 
combined with appropriate training and nutritional regimens as could be expected of the habitually 251 
trained runners included in the present study.   252 
 253 
Despite observing associations between TTN genotype and VL fascicle length in RA and marathon 254 
personal best time in MR, it remains unclear whether marathon personal best time was enhanced in the 255 
MR T-allele carriers as a consequence of possessing a shorter fascicle length, as this was not directly 256 
measured in the MR group.  As titin is suggested to be a key regulator of the Frank-Starling 257 
mechanism, the influence of TTN within cardiac muscle could provide an alternative explanation for 258 
the observed association between TTN genotype and MR personal best time.  TTN-related increases in 259 
stroke volume following endurance training have been observed previously (Rankinen et al. 2003) and 260 
the rs10497520 polymorphism appears to contribute to the training response of VO2max in previously 261 
untrained individuals (Timmons et al. 2010).  Interestingly, however, Timmons et al. (2010) observed 262 
greater gains in VO2max in CC homozygotes (those expected to have longer VL fascicles) than T-allele 263 
carriers (those expected to have shorter VL fascicles), with gains experienced by heterozygotes similar 264 
to those of TT homozygotes following training.  For untrained participants, such as those in Timmons 265 
et al., training-induced increases in VO2max are primarily due to increases in cardiac output via 266 
increases in stroke volume (Ekblom et al. 1968; Iwasaki et al. 2003) and might be accentuated in 267 
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individuals possessing the CC genotype.  However, in highly trained athletes with comparable rates of 268 
maximal oxygen uptake, as could be expected of the trained MR group, other factors such as lactate 269 
threshold and running economy are probably more important in determining performance (Conley & 270 
Krahenbuhl 1980).  Moreover, improved running economy in individuals possessing lower ratios of 271 
titin isoforms (T1/T2) has recently been reported (Pellegrino et al. 2016), although more research is 272 
required to investigate whether the rs10497520 T-allele corresponds to lower T1/T2 ratios.  Thus, 273 
despite a potential pleiotropic influence of TTN on both cardiac and skeletal muscle, possession of the 274 
T-allele (and consequently shorter VL fascicles) appears more important for marathon performance in 275 
trained individuals. 276 
 277 
Finally, as RA CC homozygotes possessed longer VL fascicles, an association of this genotype with 278 
successful sprint running performance is possible.  Longer muscle fascicles are known to contribute to 279 
enhanced Vmax (Bodine et al. 1982; Sacks & Roy 1982), which is an important determinant of sprint 280 
performance (Kumagai et al. 2000).  Thus, trained sprinters with the CC genotype might possess 281 
longer muscle fascicles and enhanced sprint ability compared to trained sprinters carrying the T-allele.  282 
Future research should investigate the impact of TTN genotype on sprint performance in addition to 283 
running economy, mechanical efficiency and Vmax, to enhance our understanding of these associations. 284 
  285 
Conclusion and Perspective 286 
Here we report, for the first time, a genetic influence on human skeletal muscle architecture.  The T-287 
allele at the rs10497520 polymorphism in TTN, the gene encoding the giant structural protein titin, is 288 
associated with shorter VL muscle fascicles in recreationally active men, and faster marathon 289 
performance (nearly 2.5 minutes faster) in habitually trained male runners with personal best times of 290 
approximately 2.5 hours.  Considering shorter muscle fascicles require less energy to produce a given 291 
force, the genotype-dependent differences in marathon personal best times may be due to differences 292 
in mechanical efficiency between T-allele carriers and CC homozygotes.   293 
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Table 1. TTN rs10497520 genotype frequency and physical characteristics for RA and MR 
participants.  Frequency data presented as count (%), all other data presented as mean (SD). 
  All CC  CT TT p X2 
 Frequency (%) 137 (100) 110 (80.3) 27 (19.7) 0 (0.0) 0.441 1.637 
R
A
 
Height (m) 1.79 (0.06) 1.79 (0.06) 1.80 (0.07) - 0.437  
Mass (kg) 75.3 (10.1)* 75.0 (9.9) 76.3 (11.1) - 0.376  
BMI (kg∙m-2) 23.5 (2.7)* 23.5 (2.7) 23.6 (3.0) - 0.806  
Age (yr) 20.7 (2.7)* 20.8 (2.6) 20.6 (3.1) - 0.768  
 VL fascicle length (cm) 7.1 (1.5) 7.3 (1.6) 6.4 (0.9)  0.003  
        
 Frequency (%) 141 (100) 108 (76.6) 32 (22.7) 1 (0.7) 0.756 0.561 
M
R
 
Height (m) 1.79 (0.07) 1.78 (0.07) 1.79 (0.06) 1.82 0.675  
Mass (kg) 66.6 (6.7) 66.7 (6.8) 66.0 (6.6) 66.0 0.551  
BMI (kg∙m-2) 20.9 (1.9) 21.0 (2.0) 20.6 (1.6) 19.9 0.285  
 Age (yr) 34.9 (7.8) 34.3 (6.7) 37.0 (10.6) 31.0 0.196  
 Marathon PB Time 
(hr:min:s) 
2:28:31 
(0:06:17) 
2:28:53 
(0:05:50) 
2:26:25 
(0:06:12) 
2:27:08 0.020  
        
T
O
T
A
L
 
Frequency (%) 278 (100) 218 (78.4) 59 (21.2) 1 (0.4) 0.385 1.908 
Height (m) 1.79 (0.07) 1.79 (0.07) 1.79 (0.06) 1.82 0.415  
Mass (kg) 70.8 (9.6) 70.9 (9.4) 70.7 (10.4) 66.0 0.834  
BMI (kg∙m-2) 22.2 (2.7) 22.2 (2.7) 21.9 (2.7) 19.9 0.452  
 Age (yr) 27.9 (9.2) 27.5 (8.5) 29.5 (11.5) 31.0  0.196  
RA, untrained; MR, habitually trained marathoners; BMI, body mass index; PB, personal best; p 
relates to two-group analyses (CC vs. CT in RA and CC vs. CT+TT in MR) except for frequency 
analyses when this includes all genotype groups; * denotes significant difference between RA and 
MR (p ≤ 1.0 x 10-13). 
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Figure 1. Comparison of VL fascicle length by TTN CC (n = 110) and CT (n = 27) genotype in RA (*p 370 
= 0.003).  No TT homozygotes were identified. Columns and error bars are mean and SD. 371 
 372 
Figure 2. Comparison of marathon personal best time between TTN CC genotype (n = 108) and T-allele 373 
carriers (n = 33) in MR (*p = 0.020). Columns and error bars are mean and SD. 374 
 375 
 376 
